Evidence map›Paper›PMID 32993150›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Nigella Sativa's Anti-Inflammatory and Antioxidative Effects in Experimental Inflammation.

Raluca Maria Pop, Octavia Sabin, Șoimița Suciu, Stefan Cristian Vesa, Sonia Ancuța Socaci, Veronica Sanda Chedea, Ioana Corina Bocsan, Anca Dana Buzoianu

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06560775 (Potential Effects of Nigella Sativa on T Lymphocytes and Inflammatory Cytokine Profile in Pediatric Systemic Lupus Erythematosus), which is not on this map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06560775 nacompletednot on this mapstarted 2022, after this paper: background citation

Potential Effects of Nigella Sativa on T Lymphocytes and Inflammatory Cytokine Profile in Pediatric Systemic Lupus Erythematosus: A Randomized Controlled Trial

TypeinterventionalSponsorUniversity of BrawijayaRan2022 to 2023Enrolled32ConditionsSLE (Systemic Lupus)ArmsStandard Treatment for SLE
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. BioMed research international · 2025
    Trial
  3. Effects ofNarra J · 2024
    Trial
  4. Foods (Basel, Switzerland) · 2026
    Article
  5. Glutamine Modulates mVOC Biosynthesis inFoods (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Analysis of Pharmacological Properties ofLife (Basel, Switzerland) · 2025
    Review
  8. Review
  9. Article
  10. Investigation of the Immunomodulatory and Neuroprotective Properties ofInternational journal of molecular sciences · 2025
    Article
  11. Article
  12. Potential of Secondary Metabolite Compounds of Black Cumin Seeds (Drug design, development and therapy · 2025
    Review
  13. Article
  14. Role ofAntioxidants (Basel, Switzerland) · 2024
    Article
  15. Review
  16. Article
  17. Chronic Treatment withInternational journal of molecular sciences · 2024
    Article
  18. International journal of molecular sciences · 2024
    Article
  19. Potential role ofCurrent molecular medicine · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Raluca Maria PopDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.ORCID 0000-0003-1899-5977
Octavia SabinDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.ORCID 0000-0003-4457-8456
Șoimița SuciuDepartment of Physiology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.
Stefan Cristian VesaDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.ORCID 0000-0003-4549-3526
Sonia Ancuța SocaciDepartment of Food Science, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, Calea Mănăştur 3-5, 400372 Cluj-Napoca, Romania.ORCID 0000-0003-0594-4628
Veronica Sanda ChedeaResearch Station for Viticulture and Enology, 515400 Blaj, Romania.
Ioana Corina BocsanDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.
Anca Dana BuzoianuDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.ORCID 0000-0002-3511-2788
Iuliu Hațieganu University of Medicine and Pharmacy · ROUniversity of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MATERIALS AND

methodsNSO was administered orally 1, 2 and 4 mL/kg in the acute phase. For subacute phase, NSO was administered 4 mL/kg, 7 days before or after inflammation induction, or in association with diclofenac 5 mg/kg.

resultsThe gas chromatography coupled with mass spectroscopy (GC-MS) analysis showed that NSO is an important source of bioactive compounds, especially p-cymene and thymoquinone. In the acute phase, 1.5 h after administration, NSO (2 and 4 mL/kg) determined an anti-inflammatory effect comparable with that of diclofenac. In the sub-acute administration, NSO had no anti-inflammatory effect. The analgesic effect of NSO was observed only in the sub-acute inflammation in the analgesy-meter test. NSO as treatment proved its antioxidant effect through the reduction of malondialdehyde (MDA) and oxidized glutathione (GSSG), and increases in hydrogen donor capacity (DH) compared to the control group, but the effect was not as intense as that of diclofenac.

conclusionThe present study has proven inconstant anti-inflammatory, analgesic and antioxidative properties of NSO.

Indexed as

anti-inflammatory effectantinociceptive effectantioxidant effectNigella sativa oilRanunculaceae

Identifiers

PMID32993150
PMCPMC7600684
OpenAlexW3088385274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.